Clinical Research Associate (In-House)
MBX Biosciences
This listing was originally posted on MBX Biosciences's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Position Summary
The Senior Clinical Research Associate (CRA) – In-House is a valuable member of our Clinical Operations Department. This individual acts as MBX’s clinical site facing ambassador, building impactful and sustainable relationships, supporting the clinical sites in proper delivery, and removing executional barriers. This position will be a key enabler of clinical sites’ success in respect to study enrollment, site relationships, data integrity and overall quality. Responsibilities will include a focus on the investigators (+ staff), regulations, compliance, timelines, data collection and review, and safety reporting. The In-house Sr. CRA may be assigned to 1-2 projects, with flexibility to assume additional project assignment(s). This position is an excellent opportunity for career development as MBX builds out the infrastructure to support our clinical pipeline.
Key Responsibilities
Education
Experience
Additional Skills and Qualifications
Company Overview
MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs, and large potential market opportunities. The Company’s pipeline includes its lead product candidate canvuparatide (MBX 2109), in Phase 2 development for the treatment of chronic hypoparathyroidism (HP); imapextide (MBX 1416), in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH); and an obesity portfolio that includes MBX 4291, with an IND currently under FDA review, as well as multiple discovery and pre-clinical candidates in development for the treatment of obesity. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at www.mbxbio.com and follow it on LinkedIn.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at MBX Biosciences?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Hormone Analogues for Rare Endocrine Diseases
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo